Lv5
970 积分 2025-04-09 加入
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
3天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
3天前
已完结
Neoadjuvant Immunochemotherapy in Resectable NSCLC with SMARCA4 Alterations
8天前
已完结
De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study
10天前
已完结
Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03)
10天前
已完结
Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+)
21天前
已完结
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma
23天前
已完结
Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
28天前
已完结
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline
30天前
已完结
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
